Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

Alibaba, Zoom Video And 76 Biggest Movers From Yesterday

Gainers Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 161.9% to close at $6.81 on Monday on heavy volume amid mention of the stock on social media.

Benzinga

The FDA Will Consider Whether To Approve a Birth Control Pill for Over-the-Counter Use

If approved, the drug could increase access to effective birth control.

Reason

FDA could approve over-the-counter purchase of first birth control pill

The agency is considering the application by HRA Pharma to make Opill available without a prescription

The Guardian - US

From analysis to the latest developments in health,
read the most diverse news in one place.

Why These Casino Stocks Are Moving Lower, Here's 45 Stocks Moving In Monday's Mid-Day Session

Gainers Pliant Therapeutics, Inc. (NASDAQ: PLRX) jumped 112.6% to $18.88 after the company said its treatment for Idiopathic Pulmonary Fibrosis was well tolerated in a Phase 2a study.

Benzinga

When it comes to darker skin, pulse oximeters fall short

These devices measure blood oxygen levels and can help identify when patients are dangerously ill. But research shows they can deliver misleading results for people with darker skin.

WEKU

Widely used hospital gowns show signs of exposing workers to infection

Disposable gowns designed to deflect the splatter of bodily fluids, used in thousands of U.S. hospitals, have underperformed in recent and ongoing laboratory tests and may fall short of safety standards, leaving health care workers with a greater risk of infection than advertised.

Tribune News Service

FDA to consider application for first over-the-counter birth control pill

"This historic application marks a groundbreaking moment in contraceptive access and reproductive equity."

Axios

Read news from The Economist, FT, and more,
with one subscription

Over-the-counter birth control? Drugmaker seeks FDA approval

A drug company is seeking U.S. approval for the first birth control pill that women could buy without a prescription

The Independent UK

Ask the Pediatrician: What should parents know about COVID-19 vaccine for children under 5?

Q: I have heard that there’s an approved COVID-19 vaccine for children under 5. What do I need to know about it?

Tribune News Service

Hopes US baby formula shortage could ease as key Abbott plant restarts

Factory in Sturgis, Michigan shut down in May after storms that produced torrential flooding

The Guardian - US

Production resumes at troubled Abbott baby formula factory

Abbot Nutrition says baby formula production has resumed at the Michigan plant whose February shutdown over contamination contributed to a national shortage

The Independent UK

Certificates issued to almost 1m people wanting to grow cannabis

The Food and Drug Administration (FDA) has issued almost 1 million electronic certificates to registrants who seek permission to cultivate cannabis following the legalisation of cannabis and hemp on June 9.

Bangkok Post

Recall alert: Do you use this dog food?

Here's everything you need to know to keep your best friend safe

Salon

ATE.TO: Phase 2 Post-Operative Pain Program to Initiate in Calendar 4Q22…

By David Bautz, PhD OTC:ATBPF | TSX:ATE.TO READ THE FULL ATE.TO RESEARCH REPORT

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - US

Biden signs executive order to protect US abortion access and urges Americans to ‘vote, vote, vote’ – as it happened

US president says electing senators who would help codify Roe v Wade is the ‘fastest route’ to solidifying federal abortion rights – follow the latest

Reason

The Food & Drug Administration Has a Vaping Problem

Something is wrong at the Food & Drug Administration's Center for Tobacco Products, and federal courts are beginning to notice.

StockNews.com

This Biotech Stock Looks Like a Prime Growth Play

Diversified healthcare company Abbott (ABT) has demonstrated significant innovations across its segments, and given its dominant market position, the company’s prospects look bright. The stock could be a solid choice as it is well-positioned to survive short-term market fluctuations. Let’s discuss this in detail….

The Guardian - US

‘Wellness’ vapes are all the rage. But are they healthy or just hype?

These ‘nutritional supplement diffusers’ claim to fight ADHD or treat anxiety or depression, but experts remain wary of effects

Get all your
news in one place.

100's of premium titles.
One news app.

Los Angeles Times

Can a Target gift card help you stay off meth? This program is trying it

LOS ANGELES — Mark had been wanting to quit using meth for a while when someone pointed him to the folding table propped up at the skid row site where homeless people stop for showers and laundry.

Benzinga

This Low-Float Stock Jumps Around 148%; Here's 64 Biggest Movers From Yesterday

Gainers United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the company's recent listing on the Nasdaq Capital Market.

Tribune News Service

Lisa Jarvis: Abortion pill won’t be the only one restricted by state bans

It’s not yet two weeks since the Supreme Court overturned Roe v. Wade, and already the ruling is impeding people’s access to drugs — including drugs not being used for abortions.

Reason

FDA Finally Admits It Caused the Baby Formula Shortage

The agency is now taking small steps to allow foreign formula manufacturers to import their goods into the U.S.

Benzinga

This EV Maker Stock Jumps More Than 9%, Here's 46 Stocks Moving In Thursday's Mid-Day Session

Gainers United Maritime Corporation (NASDAQ: USEA) jumped 180.4% to $8.02. The company’s stock jumped 190% on Wednesday after completing its spin-off from Seanergy Maritime Holdings Corp.

Benzinga

Why U.S. Stocks Are Trading Higher After Rise In Jobless Claims

U.S. stocks traded higher this morning, following the release of data on initial jobless claims.

Benzinga

The Daily Biotech Pulse: Merck's Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill

Here's a roundup of top developments in the biotech space over the last 24 hours:

1 … 184 185 186 187

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.